The Endure Absorbable PDO Sutures is a sterile, Monofilament, synthetic suture composed of Polydioxanone and the structure consists of a monofilament. They are a great choice for cases that require extended wound support for more than 4 weeks. Contraindications consist of approximation of tissue under tension and the suturing of synthetic implants (i.e. vascular grafts and cardiac valves).

WeSuture is the brand name of surgical sutures by Endure Industries. Our PDO Sutures meet the requirements of the United States Pharmacopoeia (USP) of monograph requirements for absorbable surgical sutures.

INDICATIONS

PDO Suture is indicated for use in all types of soft tissue approximation, including use in cardiovascular tissue where growth is expected to occur. PDO suture is not indicated in adult cardiovascular tissue, microsurgery, and ophthalmic and neural tissue.

PERFORMANCE

PDO suture elicits a minimal to moderate initial inflammatory tissue reaction. Progressive loss of tensile strength and eventual absorption of PDO occurs by means of hydrolysis. Absorption begins as a loss of tensile strength followed by a loss of mass. In the Biodegradability Study, In vivo strength retention was observed at 2,4,6,8 weeks in rats. In vivo strength retention of Absorbable Polydioxanone Suture was 65-70% of the original tensile strength after 4 weeks and 50-60% of the original tensile strength after 6 weeks. This result was similar to other suture products or superior to them. Absorbable Polydioxanone Suture will be absorbed in 150 days at most after implanted.

EQUIVALENT BRANDS

MonoPlus® by B. Braun and PDS® II Polydioxanone Suture by Ethicon